Small molecule tyrosine kinase inhibitors of ErbB2/HER2/Neu in the treatment of aggressive breast cancer.

Schroeder, Richard L; Stevens, Cheryl L; Sridhar, Jayalakshmi

Schroeder, Richard L; Stevens, Cheryl L; Sridhar, Jayalakshmi.

Affiliation

Schroeder RL; Department of Chemistry, Xavier University of Louisiana, 1 Drexel Drive, New Orleans, LA 70125, USA. rschroed@xula.edu.
Stevens CL; Ogden College of Science and Engineering, Western Kentucky University, 1906 College Heights Boulevard #11075, Bowling Green, KY 42101, USA. cheryl.stevens@wku.edu.
Sridhar J; Department of Chemistry, Xavier University of Louisiana, 1 Drexel Drive, New Orleans, LA 70125, USA. jsridhar@xula.edu.

Molecules ; 19(9): 15196-212, 2014 Sep 23.

Article in En | MEDLINE | ID: mdl-25251190

Subject(s)

Antineoplastic Agents/therapeutic use; Breast Neoplasms/drug therapy; Protein Kinase Inhibitors/therapeutic use; Receptor, ErbB-2/antagonists & inhibitors; Antineoplastic Agents/chemistry; Antineoplastic Agents/pharmacology; Female; Humans; Protein Kinase Inhibitors/chemistry; Protein Kinase Inhibitors/pharmacology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Receptor, ErbB-2 / Protein Kinase Inhibitors / Antineoplastic Agents Limits: Female / Humans Language: En Journal: Molecules Journal subject: BIOLOGIA Year: 2014 Type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google